Devices descending from K081920
18 later devices reach BD Geneohm Cdiff Assay through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K130470 | BD Max Cdiff Assay, BD Max Instrument | Geneohm Sciences Canada, Inc. (Bd Diagnostics) | 2013 | 10 | 2 |
| +1 | K113433 | Simplexa C. Difficile Universal Direct | Focus Diagnostics, Inc. | 2012 | 0 | — |
| +1 | K110203 | Xpert C. Difficle/Epi Assay | Cepheid | 2011 | 1 | — |
| +1 | K091109 | Xpert C. Difficile | Cepheid | 2009 | 5 | — |
| +1 | K090239 | Progastro CD Assay | Prodesse, Inc. | 2009 | 0 | — |
| +2 | K172569 | GenePOC CDiff | Genepoc, Inc. | 2017 | 1 | 1 |
| +2 | K163085 | Simplexa C. difficile Direct; Simplexa C. difficile Positive Control Pack | Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC | 2017 | 0 | — |
| +2 | K142422 | cobas Cdiff Test | Roche Molecular Systems, Inc. | 2015 | 5 | — |
| +2 | K132726 | Iceplex C. Difficile Assay Kit, Iceplex System | Primeradx | 2013 | 0 | — |
| +2 | K123197 | Verigene C. Difficile Nucleic Acid Test (CDF) | Nanosphere, Inc. | 2012 | 0 | 4 |
| +2 | K100818 | Illumigene C. Difficile, Illumipro-10 and Illumigene C. Difficile External Control Kit… | Meridian Bioscience, Inc. | 2010 | 2 | — |
| +3 | K232092 | Great Basin Toxigenic C. difficile Direct Test (CDF2) | Vela Operations USA | 2023 | 0 | — |
| +3 | K171770 | cobas Cdiff Nucleic acid test for use on the cobas Liat System | Roche Molecular Systems, Inc. | 2017 | 4 | — |
| +3 | K110012 | Illumigene C. Difficile, and Illumipro-10 | Meridian Bioscience, Inc. | 2011 | 1 | 2 |
| +4 | K212427 | cobas Cdiff nucleic acid test for use on the cobas Liat System | Roche Molecular Systems, Inc. | 2021 | 2 | — |
| +4 | K210385 | cobas Cdiff nucleic acid test for use on the cobas Liat System | Roche Molecular Systems, Inc. | 2021 | 0 | — |
| +5 | K260045 | cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas®… | Roche Molecular Systems, Inc. | 2026 | 0 | — |
| +5 | K243730 | Xpert C. difficile/Epi | Cepheid® | 2025 | 0 | — |